lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
213 rows where filing_period = "third_quarter", filing_year = 2009 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 743680 | RUBICON ADVISORS, LLC 9d7e8c3d-2b56-4810-8499-012c982b3214 | 3A | RUBICON ADVISORS, LLC | 315091 | GILEAD SCIENCES | 2009 | third_quarter | PHA | H.R. 822, H.R. 1943, H.R. 6114, S-2969 | 75000 | 0 | 0 | 2009-02-10T20:06:50-05:00 | ||
| 821512 | HOLLAND & KNIGHT LLP 2f2d1d9a-75bb-4ac7-9832-108c47712a34 | Q3 | HOLLAND & KNIGHT LLP | 18466 | AMERICAN SOCIETY OF HEMATOLOGY | 2009 | third_quarter | PHA | Hematology and Oncology drug research and approval issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2009-09-30T10:29:59-04:00 | |
| 821521 | HOLLAND & KNIGHT LLP c495c6b4-a622-49c0-af64-2882c39edcd3 | Q3 | HOLLAND & KNIGHT LLP | 18466 | NATIONAL HEMOPHILIA FOUNDATION | 2009 | third_quarter | PHA | Blood and blood product safety; issues related to blood product approvals. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2009-09-30T10:35:03-04:00 | |
| 821880 | MR. THEODORE (TED) JONES 2cdcbfdc-f0a8-455c-a4a8-26e900172402 | Q3 | MR. THEODORE (TED) JONES | 20926 | PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA | 2009 | third_quarter | PHA | Trade Association for certain Pharmaceutical Companies | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2009-10-01T16:34:10-04:00 | |
| 821994 | CYBER SECURITY RESEARCH CONSULTANTS, LLC 420eac77-49c2-416f-92d5-e5113924d8a5 | Q3 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2009 | third_quarter | PHA | Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe drug reimportation from Canada Health Care Reform | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2009-10-02T11:44:50-04:00 | |
| 823140 | CAPITOL HILL CONSULTING GROUP 1d74c4ba-4d6c-49ed-a999-f3b1aba33c39 | Q3 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2009 | third_quarter | PHA | Controlled Drug Substances Act (21 USC 13) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2009-10-06T17:00:18-04:00 | |
| 823358 | HOLLAND & KNIGHT LLP d258e831-787a-4758-b149-d5ecacde2351 | Q3 | HOLLAND & KNIGHT LLP | 18466 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2009 | third_quarter | PHA | Issues relating to the biotechnology industry. | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2009-10-07T12:25:00-04:00 | |
| 823802 | PARRY, ROMANI, DECONCINI & SYMMS 87561aaa-14ef-47ee-b926-239058546a67 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AMERICAN ASSOCIATION FOR HEALTH FREEDOM | 2009 | third_quarter | PHA | Support of legislation and efforts to guarantee access by health professionals and patients to medications such as estriol and other compounded preparations. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-10-08T11:50:32-04:00 | |
| 823947 | DUTKO WORLDWIDE, LLC b4bae6fb-4567-470c-b05d-fbd516b47e1b | Q3 | DUTKO WORLDWIDE, LLC | 12868 | NEWAYS INTERNATIONAL | 2009 | third_quarter | PHA | Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-10-08T14:32:39-04:00 | |
| 823962 | PARRY, ROMANI, DECONCINI & SYMMS 2c980906-f1b1-4b95-9af7-498b9ace3fda | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2009 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2009-10-08T14:36:46-04:00 | |
| 824062 | PARRY, ROMANI, DECONCINI & SYMMS c525d7dd-39e5-4261-9dc4-7225397e0f60 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2009 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2009-10-08T15:57:38-04:00 | |
| 824107 | PARRY, ROMANI, DECONCINI & SYMMS e8fb36fb-6cb0-46a4-8180-c308fcccba84 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2009 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2009-10-08T16:47:58-04:00 | |
| 824112 | PARRY, ROMANI, DECONCINI & SYMMS dad52946-3a8c-420c-a11f-5da434cc1b23 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2009 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2009-10-08T16:55:01-04:00 | |
| 824340 | JULIE PHILP 939ecf5f-486d-43d7-9d8a-f485b851f9eb | Q3 | JULIE PHILP | 400407928 | NATIONAL GRASSROOTS AND COMMUNICATION | 2009 | third_quarter | PHA | Medicare and Medicaid issues; HR 1204, an antitrust examption for independent pharmacists to negotiate with private insurers and pharmacy benefit managers; HR 3200, to incluse pharmacy provisions to increase generic utilization of medications, provide for pharmacy benefit manager transparency, and increase dispensing fees for pharmacies. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-10-09T11:30:23-04:00 | |
| 824661 | AMERICAN COLLEGE OF CLINICAL PHARMACY ad242758-dc5a-47bd-b1d1-9bb4e8eeb672 | Q3 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2009 | third_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare Part B and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 59700 | 0 | 0 | 2009-10-09T16:17:00-04:00 | |
| 825315 | SQUIRE PATTON BOGGS 1f6d5ecf-5d79-4945-8f66-885572b8019d | Q3 | SQUIRE PATTON BOGGS | 30906 | KERR CORPORATION | 2009 | third_quarter | PHA | Issues related to FDA enforcement action against counterfeits of client's medical devices. | HOUSE OF REPRESENTATIVES | 0 | 0 | 2009-10-13T08:38:01-04:00 | ||
| 825416 | INDEPENDENT PHARMACY COOPERATIVE 8504e48a-07bd-46c1-b577-578696c9dad1 | Q3 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2009 | third_quarter | PHA | H.R. 3200 America's Affordable Health Choices Act of 2009. DMEPOS exemption and Average Manufacturer Price FULprovisions for pharmacy. Senate Finance Health Reform draft legislation. DMEPOS exemption and Average Manufacturer Price FUL provisions for pharmacy. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-10-13T10:35:04-04:00 | |
| 825429 | POLICY DIRECTIONS INC. e4ff8646-97c7-4260-9646-8d26449c96c0 | Q3 | POLICY DIRECTIONS INC. | 31747 | ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) | 2009 | third_quarter | PHA | Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. | Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2009-10-13T10:40:14-04:00 | |
| 825853 | GREATER NEW YORK HOSPITAL ASSOCIATION 9c9099ce-348a-4e9c-b3ff-f87e311812d1 | Q3 | GREATER NEW YORK HOSPITAL ASSOCIATION | 16830 | GREATER NEW YORK HOSPITAL ASSOCIATION | 2009 | third_quarter | PHA | Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); America's Healthy Futures Act (Senate Finance Committee bill); House Tri-Committee bill (H.R. 3200); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239)) | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE,White House Office | 370000 | 0 | 0 | 2009-10-13T14:14:14-04:00 | |
| 825917 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) d525b4f4-bc20-4a83-aea9-92df9bbed714 | Q3 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2009 | third_quarter | PHA | Importation of prescription drugs (S. 525/S. 1232/H.R. 1298) Rx Pedigree Pharmacy Accreditation Delay (H.R. 3663) | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 190000 | 0 | 0 | 2009-10-13T14:33:38-04:00 | |
| 826148 | FIERCE, ISAKOWITZ & BLALOCK b6b47a79-eaac-4ef6-86da-6a18f00f3fab | Q3 | FIERCE, ISAKOWITZ & BLALOCK | 44812 | MOMENTA PHARMACEUTICALS, INC. | 2009 | third_quarter | PHA | Generic Biologics: -S726/H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act -H.R.1548: Pathway for Biosimilars Act -S.1679 Affordable Health Choices Act | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 20000 | 0 | 0 | 2009-10-13T15:41:41-04:00 | |
| 826649 | MEREDITH MCGEHEE a41898a4-cf64-4871-8132-d8e01307166d | Q3 | MEREDITH MCGEHEE | 79858 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2009 | third_quarter | PHA | Funding for programs to develop AIDS vaccines targeted toward the developing world; Educating about research and development programs aimed at the AIDS epidemic; Implementation of PEPFAR; Appropriations for USAID R&D and funding for IAVI; Providing information on Protocol G work and "The Antibody Project"; Role of FDA in vaccines for developing world | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-10-14T10:27:16-04:00 | |
| 827417 | VENABLE LLP 450e023c-bcb4-4269-92a1-0b3a602a35b6 | Q3 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2009 | third_quarter | PHA | General issues affecting the pharmaceutical industry. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2009-10-14T15:56:21-04:00 | |
| 827624 | THE UNITED STATES PHARMACOPEIAL CONVENTION c617db9d-33e8-473b-bc21-03a88467d2cc | Q3 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 400358632 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 2009 | third_quarter | PHA | - HR 1859, "Independent Drug Education & Outreach Act", regarding all provisions as a neutral, expert scientific resource. - S 726, "Promoting Innovation and Access to Lifesaving Medicine Act, regarding all provisions. - Issues relating to heparin. - Information regarding USP General Chapter <1> Injections - labeling on ferrules and cap overseals, specifically to update Congress on USP standards. - Information on follow-on biologics. - Information on drug quality as a neutral, expert scientific resource. | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 90000 | 0 | 0 | 2009-10-14T16:57:17-04:00 | |
| 827802 | PRO UNLIMITED 9b5913da-151a-4073-aa95-55b32e268281 | Q3 | PRO UNLIMITED | 400412954 | SANOFI-AVENTIS U S INC | 2009 | third_quarter | PHA | Manufacturing pricing or rebate obligations for heath benefits related to pharmaceuticals; Medicare, Medicaid and veterans administration and public health service programs | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2009-10-14T18:14:43-04:00 | |
| 827839 | WINBORN SOLUTIONS LLC cafd10a3-00f6-4d0f-9d35-550932732dcc | Q3 | WINBORN SOLUTIONS LLC | 308310 | PERRIGO CO | 2009 | third_quarter | PHA | Dextromethorphan Distribution Act of 2009 Food and drug safety, user fee and country of origin legislation | HOUSE OF REPRESENTATIVES,SENATE | 18000 | 0 | 0 | 2009-10-14T19:27:11-04:00 | |
| 828121 | VAN SCOYOC ASSOCIATES 6db6180a-4b79-4a18-8017-0f6c11d50ba9 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF CONNECTICUT | 2009 | third_quarter | PHA | H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) | 40000 | 0 | 0 | 2009-10-15T09:18:02-04:00 | |
| 828131 | VAN SCOYOC ASSOCIATES 4898e28f-6c35-4c58-8263-af9aad76517d | Q3 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF MARYLAND BALTIMORE | 2009 | third_quarter | PHA | H.R.2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-10-15T09:20:05-04:00 | |
| 828146 | VAN SCOYOC ASSOCIATES 6f1a5f34-a555-454d-917f-229ba8d4902d | Q3 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE | 2009 | third_quarter | PHA | H.R.2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA and USDA funding initiatives. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2009-10-15T09:22:07-04:00 | |
| 828890 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS df2be76a-ebde-4ad5-8126-b9dcb7389619 | Q3 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2009 | third_quarter | PHA | Meeting with FDA relating to removal of unapproved products, opportunities for future collaboration; Risk Evaluation and Mitigation Strategies. Meeting with FDA regarding design and use of NDC number. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 250000 | 0 | 0 | 2009-10-15T12:33:24-04:00 | |
| 829397 | PARRY, ROMANI, DECONCINI & SYMMS 81d8d2fa-8795-44b4-be24-b5cd59bd9628 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ) | 2009 | third_quarter | PHA | No specific legislation or bills introduced at this time. Medicare reimbursement issues. | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2009-10-15T14:50:09-04:00 | |
| 829464 | BROWN RUDNICK LLP dc133446-cd5e-44c0-8bf5-2781f364f1d4 | Q3 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2009 | third_quarter | PHA | S.525 & H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-10-15T15:01:18-04:00 | |
| 829899 | FABIANI & COMPANY 45dc20bf-bde5-45f7-8fac-2fdf490d38a2 | Q3 | FABIANI & COMPANY | 72576 | ACORDA THERAPEUTICS, INC. | 2009 | third_quarter | PHA | Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-10-15T16:48:05-04:00 | |
| 829930 | FABIANI & COMPANY aa6841b4-57da-4a67-89a8-e6745d288c67 | 3A | FABIANI & COMPANY | 72576 | ACORDA THERAPEUTICS, INC. | 2009 | third_quarter | PHA | Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-10-15T17:02:19-04:00 | |
| 829971 | FLYNN & ASSOCIATES, INC. fae010af-97cc-4704-8847-5556bb00ee89 | Q3 | FLYNN & ASSOCIATES, INC. | 15020 | PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION | 2009 | third_quarter | PHA | Patent Life Issues Healthcare Reform Pharmaceutical industry employment issues | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2009-10-15T17:14:42-04:00 | |
| 830878 | MASSACHUSETTS MEDICAL SOCIETY 0ca4c715-ae9b-4540-a1ce-fcd359afd7a8 | Q3 | MASSACHUSETTS MEDICAL SOCIETY | 23975 | MASSACHUSETTS MEDICAL SOCIETY | 2009 | third_quarter | PHA | S. 301, Physician Payment Sunshine Act legislation which would require pharmaceutical companies and device manufactures to disclosure gifts and other contributions to physicians | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 80000 | 0 | 0 | 2009-10-16T10:43:26-04:00 | |
| 831403 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES fc9322bc-91ea-49c6-ba1e-2df7a9645284 | Q3 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2009 | third_quarter | PHA | H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1256, the Family Smoking Prevention and Tobacco Control Act, as related to the importation of prescription drugs. H.R. 1298/S.525,S.1232, Pharmaceutical Market Access and Drug Safety Act, as related to the importation of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R. 1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals by the FDA. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Bart B surety bond requirement. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act, as related to the abuse of methamphetamine. H.R. 2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010, as related to the importation of prescription drugs. H.R. … | Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,White House Office | 720000 | 0 | 0 | 2009-10-16T11:44:40-04:00 | |
| 831817 | BUCHANAN INGERSOLL & ROONEY PC 4c113b4c-2d8e-4baf-b1d3-0fd2cf15699e | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | AVI BIOPHARMA, INC. | 2009 | third_quarter | PHA | Biodefense funding issues in the US House, US Senate and other agencies. | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-10-16T12:35:14-04:00 | ||
| 831829 | BUCHANAN INGERSOLL & ROONEY PC 335dea9c-f3cd-4324-838f-10305281910e | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | BIOFACTURA | 2009 | third_quarter | PHA | Biotechnology, Disaster Planning, Homeland Security, Science & Technology and Pharmacy issues with the US House, US Senate and Federal Agencies | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-10-16T12:36:17-04:00 | ||
| 831870 | AMYLIN PHARMACEUTICALS 9a85cbf6-6738-45e5-9e11-452a51fbe7bd | Q3 | AMYLIN PHARMACEUTICALS | 308536 | AMYLIN PHARMACEUTICALS | 2009 | third_quarter | PHA | Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Physician Payments Sunshine provision of H.R. 3200 America's Affordable Health Choices Act of 2009 FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 330000 | 0 | 0 | 2009-10-16T12:45:25-04:00 | |
| 831888 | EISAI INC. 0ca271c1-62e4-45b3-9e9b-5024186ca08c | Q3 | EISAI INC. | 400321512 | EISAI INC. | 2009 | third_quarter | PHA | Establishment of pathway for the approval of biosimilars in health reform legislation HR 1427, Promoting Innovation and Access to Life-Saving Medicine Act HR 1548, Pathway for Biosimilars Act S. 369, Preserve Acess to Affordable Generics Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act | HOUSE OF REPRESENTATIVES,SENATE | 810000 | 0 | 0 | 2009-10-16T12:47:59-04:00 | |
| 831973 | EXPRESS SCRIPTS, INC. 912146cc-02aa-4f50-baa7-0527ebc03490 | Q3 | EXPRESS SCRIPTS, INC. | 294416 | EXPRESS SCRIPTS, INC. | 2009 | third_quarter | PHA | Items related to reverse settlement payments between manufacturers--HR 1706, S. 369 Items related to oversight of the federal employees health benefits program and its pharmacy benefit Design and coverage of pharmacy benefits in new Health Exchanges/Gateways as well as pharmacy benefit managers transparency requirements--America's Healthy Future Act, S. 1679, HR 3200 | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 280000 | 0 | 0 | 2009-10-16T13:02:53-04:00 | |
| 832504 | BUCHANAN INGERSOLL & ROONEY PC dfdf7c1e-1cca-43b6-af4f-1cf0eadf2e34 | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | IPEC - AMERICAS, INC. | 2009 | third_quarter | PHA | FDA Globalization Acts and legislation related to supply chain security and drug contaminations issues | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-10-16T14:41:09-04:00 | |
| 832843 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 11650e1f-230b-4091-8df1-3802657c2c98 | Q3 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 27478 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2009 | third_quarter | PHA | H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 100th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; (more) Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements and small business tax provisions; H.R. 1166 (E-Fencing Enforcement Act of 2009), H.R. 1173 (Organized Retail Crime Act of 2009) and S. 470 (Combating Organized Retail Crime Act of 2009); H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009; S. 1383, the "Dextromethorphan Abuse Reduction Act; and "H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy management, public plan option and requirements for businesses to provide health insurance, and pharmacy benefit manager transparency requirements. | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE | 180000 | 0 | 0 | 2009-10-16T15:22:29-04:00 | |
| 833293 | BUCHANAN INGERSOLL & ROONEY PC 5b3b49c0-0e52-481f-8f22-21af8deff17a | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | SHIRE PHARMACEUTICALS INC | 2009 | third_quarter | PHA | Pathway for follow-on biologics; orphan drugs, healthcare reform; DEA quota. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-10-16T16:38:20-04:00 | |
| 833357 | JOHNS HOPKINS UNIVERSITY cd515b3c-8538-42ed-9c12-cde1f6f8a5c4 | Q3 | JOHNS HOPKINS UNIVERSITY | 20664 | JOHNS HOPKINS UNIVERSITY | 2009 | third_quarter | PHA | H.R. 444, 340B Program Improvement and Integrity Act of 2009. Issues regarding extending 340B outpatient pharmaceutical discount to the inpatient setting. | HOUSE OF REPRESENTATIVES,SENATE | 220000 | 0 | 0 | 2009-10-16T16:48:23-04:00 | |
| 833512 | BUCHANAN INGERSOLL & ROONEY PC dbaffbb9-92ce-49d9-ae93-adc47992fe5c | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | XOMA | 2009 | third_quarter | PHA | Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate. | Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 20000 | 0 | 0 | 2009-10-16T17:20:41-04:00 | |
| 833726 | US STRATEGIES 3b015271-ad7a-443a-a527-8779b56eb980 | Q3 | US STRATEGIES | 38825 | NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT) | 2009 | third_quarter | PHA | Medicare and Medicaid provisions relating to pharmacy and medication management policies | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-10-16T18:33:26-04:00 | |
| 833983 | PODESTA GROUP, INC. c0262eca-a278-4730-8d4f-6d1722053747 | Q3 | PODESTA GROUP, INC. | 31680 | BRISTOL-MYERS SQUIBB | 2009 | third_quarter | PHA | H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-10-17T16:18:32-04:00 | |
| 833990 | PODESTA GROUP, INC. 7d5c09a3-3698-4625-a928-ea4f5f90bf49 | Q3 | PODESTA GROUP, INC. | 31680 | CUBIST PHARMACEUTICALS INC | 2009 | third_quarter | PHA | Medical Research Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues Antibiotic Resistance Issues H.R. 2400 Strategies to Address Antimicrobial Resistance Act (STAAR) H.R. 2937 MRSA Infection Prevention and Patient Protection Act S. 369 Preserve Access to Affordable Generics Act of 2009 | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2009-10-17T16:19:34-04:00 | |
| 833993 | PODESTA GROUP, INC. a6364324-7555-4aa1-a652-55975f959788 | Q3 | PODESTA GROUP, INC. | 31680 | EISAI INC. | 2009 | third_quarter | PHA | H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act S. 369 Preserve Access to Affordable Generics Act | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-10-17T16:20:36-04:00 | |
| 833996 | PODESTA GROUP, INC. 7d9a85b7-6054-4edf-97fc-e1666b82275a | Q3 | PODESTA GROUP, INC. | 31680 | EMD SERONO INC | 2009 | third_quarter | PHA | H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug importation H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009 | HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE | 60000 | 0 | 0 | 2009-10-17T16:21:38-04:00 | |
| 834004 | PODESTA GROUP, INC. 591314ee-3b53-4971-ba09-04e19c3c1220 | Q3 | PODESTA GROUP, INC. | 31680 | WINNING STRATEGIES WASHINGTON LLC | 2009 | third_quarter | PHA | Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues Kennedy American Health Choices Act of 2009 H.R. 3200 American Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill Baucus/Finance Healthcare Reform Bill - America's Healthy Future Act of 2009 H.R. 616 Pharmacists Exemption to CMS DME Requirements | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-10-17T16:23:48-04:00 | |
| 834262 | TARPLIN STRATEGIES LLC 4a3a28e4-bd91-4681-b34b-71e59ad2806b | Q3 | TARPLIN STRATEGIES LLC | 40032282 | GENENTECH, INC. | 2009 | third_quarter | PHA | H.R. 1548, the Pathway for Biosimilars Act, FDA approval of follow-on biologics. H.R. 1427 and S. 726, the Promoting Innovation and Access to Life-Saving Medicine Act, FDA approval of follow-on biologics. H.R. 3200, America's Affordable Health Choices Act - FDA approval of follow-on biologics and length of data exclusivity period. S. 1679, the Affordable Health Choices Act - FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program. Senate Finance Committee Chairman's Mark, America's Healthy Future Act - Medicare and Medicaid reimbursement issues, possible taxes and fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit. S. 1232, the Pharmaceutical Market Access and Drug Safety Act, importation of prescription drugs. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2009-10-18T15:40:26-04:00 | |
| 834376 | FIERCE, ISAKOWITZ & BLALOCK 5f91dc15-fdf6-447f-bfbd-f8fac7f7f283 | Q3 | FIERCE, ISAKOWITZ & BLALOCK | 44812 | COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET | 2009 | third_quarter | PHA | Generic Biologics: -S726/H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act -H.R.1548: Pathway for Biosimilars Act -S.1679 Affordable Health Choices Act Americas Health Future Act of 2009 -Biosimilar Reimbursement Utilization Equity Amendment -Limited Exception to Anti-Kickback Statute to Waive Co-payments For Generic Drugs | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-10-18T18:50:55-04:00 | |
| 834503 | POLICY ADVOCATES 703b63a4-41a5-4e3d-ab98-ccf797df2846 | Q3 | POLICY ADVOCATES | 72018 | PHOENIX CAPITAL MANAGEMENT LLC | 2009 | third_quarter | PHA | Track and monitor Internet Pharmacy Issues. | HOUSE OF REPRESENTATIVES,SENATE | 22500 | 0 | 0 | 2009-10-19T07:25:44-04:00 | |
| 834612 | INDEPENDENCE BLUE CROSS f28690fa-d36c-4580-8ab0-d6d1cc18e6c3 | Q3 | INDEPENDENCE BLUE CROSS | 19172 | INDEPENDENCE BLUE CROSS | 2009 | third_quarter | PHA | Restructuring FEHBP Rx benefits | Congressional Budget Office (CBO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 0 | 0 | 2009-10-19T09:05:32-04:00 | ||
| 834701 | AMERICAN VETERINARY MEDICAL ASSOCIATION d9235a8e-5a2e-44a5-b915-9bf75c48fb8a | Q3 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 3630 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 2009 | third_quarter | PHA | H.R. 1549/S. 619, Preservation of Antibiotics for Medical Use Act | Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 130000 | 0 | 0 | 2009-10-19T09:27:01-04:00 | |
| 834747 | UNIVERSITY OF CONNECTICUT 743bebb4-d30d-488a-b1f1-a04b4a180dcd | Q3 | UNIVERSITY OF CONNECTICUT | 39382 | UNIVERSITY OF CONNECTICUT | 2009 | third_quarter | PHA | H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) | 70000 | 0 | 0 | 2009-10-19T09:35:07-04:00 | |
| 834796 | U.S. CHAMBER INSTITUTE FOR LEGAL REFORM 4ae8657f-5a0c-48a4-b643-e4ab3f3eeb3b | Q3 | U.S. CHAMBER INSTITUTE FOR LEGAL REFORM | 51172 | U S CHAMBER INSTITUTE FOR LEGAL REFORM | 2009 | third_quarter | PHA | S. 540/H.R. 1346, Medical Device Safety Act of 2009 General background on drug and device labeling rules and the doctrine of Federal preemption (no specific legislation introduced) | HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Securities & Exchange Commission (SEC),SENATE | 4240000 | 0 | 0 | 2009-10-19T09:39:30-04:00 | |
| 834901 | APTIV, PLC ac207965-6e00-4d99-a74d-6a49ac7a8fff | Q3 | APTIV, PLC | 49054 | APTIV PLC | 2009 | third_quarter | PHA | No activity this quarter | Energy, Dept of,Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Pension Benefit Guaranty Corporation (PBGC),SENATE,Transportation Security Administration (TSA) | 190000 | 0 | 0 | 2009-10-19T09:51:56-04:00 | |
| 834999 | CHAMBER OF COMMERCE OF THE U.S.A. 102e20ba-30c8-4c21-b276-cef0795b7d8c | Q3 | CHAMBER OF COMMERCE OF THE U.S.A. | 38756 | CHAMBER OF COMMERCE OF THE U.S.A. | 2009 | third_quarter | PHA | H.R. 1346/S. 540, Medical Device Safety Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009 America's Healthy Future Act of 2009 (Bill number not yet available) | Agriculture, Dept of (USDA),Army, Dept of (Corps of Engineers),Commerce, Dept of (DOC),Consumer Product Safety Commission (CPSC),Defense, Dept of (DOD),Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Executive Office of the President (EOP),Federal Accounting Standards Advisory Board (FASAB),Federal Communications Commission (FCC),Federal Reserve System,Federal Trade Commission (FTC),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Labor, Dept of (DOL),Maritime Administration (MARAD),Natl Aeronautics & Space Administration (NASA),Natl Economic Council (NEC),Natl Labor Relations Board (NLRB),Natl Mediation Board,Natl Security Council (NSC),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),St. Lawrence Seaway Development Corporation,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Fish & Wildlife Service (USFWS),U.S. Trade Representative (USTR),White House Office | 34690000 | 0 | 0 | 2009-10-19T10:02:22-04:00 | |
| 835340 | KIRKLAND & ELLIS LLP c19c0300-0084-4cd7-b356-4de5771d9054 | Q3 | KIRKLAND & ELLIS LLP | 21745 | TEVA PHARMACEUTICALS USA | 2009 | third_quarter | PHA | House and Senate legislation on biologic medicines. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-10-19T10:35:27-04:00 | ||
| 835549 | MOFFETT GROUP, LLC 563c852f-f203-4ed1-8a51-f416eadea87d | Q3 | MOFFETT GROUP, LLC | 82578 | BOEHRINGER INGELHEIM PHARMECEUTICAL | 2009 | third_quarter | PHA | Phamaceutical issues, especially with respect to the House Energy and Commerce Committee. Our work is specifically related to the Connecticut delegation. | HOUSE OF REPRESENTATIVES,SENATE | 51293 | 0 | 0 | 2009-10-19T10:50:39-04:00 | |
| 835751 | WINNING STRATEGIES WASHINGTON ad00a43b-03d8-4d89-8d44-c1b2b9c62544 | Q3 | WINNING STRATEGIES WASHINGTON | 50796 | DIABETES ACCESS TO CARE COALITION (DACC) | 2009 | third_quarter | PHA | Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program issues Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill H.R. 616, S. 511 Pharmacists Exemption to CMS DME Requirements H.R. 1970, S. 956, the Preserve Patient Access to Reputable DMEPOS Providers Act | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-10-19T11:06:21-04:00 | |
| 836403 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM fc012bf3-9811-4fa6-a465-4043e60629be | Q3 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 58534 | ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 2009 | third_quarter | PHA | HR 444, 3200; S1239, Senate Finance Committee To amend section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers; any language expanding 340B drug discounts to inpatient settings. | HOUSE OF REPRESENTATIVES,SENATE | 47778 | 0 | 0 | 2009-10-19T11:52:24-04:00 | |
| 836540 | MEHLMAN CONSULTING, INC. 809a92eb-daba-48ea-9562-db013b8aaf66 | Q3 | MEHLMAN CONSULTING, INC. | 284950 | ABBOTT LABORATORIES | 2009 | third_quarter | PHA | Health care reform: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choice Act. Food & Drug Administration reforms; Medicare coverage and reimbursement. Follow on Biologics: H.R.1548, Pathway for Biosimilars Act. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-10-19T12:00:01-04:00 | |
| 836865 | TWENTY-FIRST CENTURY GROUP, INC. 5d9c643f-dbf5-43ba-96c4-b5ec165fd3d0 | Q3 | TWENTY-FIRST CENTURY GROUP, INC. | 38687 | SCHERING-PLOUGH | 2009 | third_quarter | PHA | General pharmaceutical issues. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-10-19T12:24:02-04:00 | |
| 836971 | ASSOCIATION FOR ACCESSIBLE MEDICINES 7b533b71-936d-47a6-a6ce-67e6c0dbd5ea | Q3 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 16032 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 2009 | third_quarter | PHA | Generic Biologics, including but not limited to: H.R.1427, H.R.1548, and S.726 Prescription Drug Safety Counterfeit Drugs/Import Safety/Pedigree, such as: H.R.759 Authorized Generics, including, but not limited to: S.501 and H.R.573 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR),White House Office | 508363 | 0 | 0 | 2009-10-19T12:36:34-04:00 | |
| 837933 | BUCHANAN INGERSOLL & ROONEY PC 147dad37-5b30-40a3-bbbc-886deaa727f6 | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | GENERIC ANIMAL DRUG ALLIANCE | 2009 | third_quarter | PHA | Legislative issues relating to United States Food & Drug Administration. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-10-19T14:04:30-04:00 | ||
| 838113 | GILBERT'S LLP 80cc479f-de05-426d-be75-841f730f4747 | Q3 | GILBERT'S LLP | 67876 | MYLAN LABORATORIES INC | 2009 | third_quarter | PHA | Reform to legislation and regulations affecting pharmaceutical drug approval and marketing | Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2009-10-19T14:19:01-04:00 | |
| 838189 | THE KROGER CO. 53f8cc6b-e79a-4f47-a0ca-b09b8140bbe1 | Q3 | THE KROGER CO. | 88212 | KROGER CO | 2009 | third_quarter | PHA | S. 511 Access to Durable Medical Equipment Act | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2009-10-19T14:24:21-04:00 | |
| 838421 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION d37380b5-c162-4d9d-b206-8aae7280faaa | Q3 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 31348 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 2009 | third_quarter | PHA | Items related to the application of drug benefits to public plans and health exchange, including PBM disclosure, in HR 3200, S 1679 Americas Health Future Act | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE | 325548 | 0 | 0 | 2009-10-19T14:38:25-04:00 | |
| 838681 | OGR ce3ffaae-01de-405f-b2a3-f9be5eb3c130 | Q3 | OGR | 48827 | SANOFI PASTEUR | 2009 | third_quarter | PHA | vaccine related issues | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-10-19T14:56:15-04:00 | |
| 838702 | FOLEY & LARDNER LLP b891b0ae-77e2-4e78-9129-642f7e7618ab | Q3 | FOLEY & LARDNER LLP | 15042 | UNITED THERAPEUTICS | 2009 | third_quarter | PHA | Approval and funding for development and application of broad spectrum antiviral drugs | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-10-19T14:58:16-04:00 | |
| 838737 | THE OB-C GROUP, LLC f798747a-832d-48a7-8496-f73df534d49d | Q3 | THE OB-C GROUP, LLC | 29802 | ELI LILLY | 2009 | third_quarter | PHA | HR 1548, Pathway for Biosimilars Act: entire bill. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-10-19T14:59:33-04:00 | |
| 838796 | MCDERMOTT WILL & SCHULTE LLP 9db45229-c844-4c16-8444-3c2298139139 | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION | 2009 | third_quarter | PHA | Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-10-19T15:03:51-04:00 | |
| 838853 | VAN NESS FELDMAN, LLP b4ceab4d-d4d0-4c83-8d28-0f2b130c04ab | Q3 | VAN NESS FELDMAN, LLP | 39815 | MCKESSON CORPORATION | 2009 | third_quarter | PHA | H.R. 3200, America's Affordable Health Choices Act of 2009 America's Healthy Future Act H.R. 3108, Medication Therapy Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-10-19T15:06:23-04:00 | |
| 838870 | AMERICAN PHARMACISTS ASSOCIATION 98366d13-ebfd-4162-ac71-86b20ca44c9c | Q3 | AMERICAN PHARMACISTS ASSOCIATION | 3071 | AMERICAN PHARMACISTS ASSOCIATION | 2009 | third_quarter | PHA | HR1204 - The Community Pharmacy Fairness Act of 2009 S80 - Pharmaceutical Market Access Act of 2009 HR1298/S525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR163 - Prescription Drug Affordability Act HR2400 - Strategies to Address Antimicrobial Resistance Act HR1706 - Protecting Consumer Access to Generic Drugs Act of 2009 HR3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all Pharmacy-Based Communications (Docket Number FDA2008N0038) Risk Communication Advisory Committee; Notice of Meeting on the types of communications that patients receive at the pharmacy includes: medication guides; patients package inserts; and consumer medication information (Docket Number FDA2009D0181) Draft Guidance for Industry on Label Comprehension Studies for Nonprescription Drug Products;Availability (Docket Number FDA2009N0295) Providing Effective Information to Consumers About Prescription Drug Risks and Benefits; Public Workshop (Docket Number FDA1977N0013) (formerly Docket No. 1977N0094L) Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph (Docket Number FDA2009N0143) Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting (Docket Number FDA2006N0238) (formerly Docket No. 2006N0062) Expanded Access to Investigational Drugs for Treatment Use (Docket Number FDA2006N0237) (formerly Docket No. 2006N0061) Charging for Investigational Drugs Under an Investigational New Drug Application (Docket Number FDA2009N0247) Food and Drug Administration Transparency Task Force; Reopening of Comment Period (Docket Number DEA321a) Identification of Institution-based Individual Practitioners (Docket Number FDA2009N0374) Educating the Public About Removal of Essential-Use Designation for Epinephrine; Public Workshop; Request for Comments (Docket Number FDA2009N0441) Promotio… | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Indian Health Service,SENATE,White House Office | 157696 | 0 | 0 | 2009-10-19T15:08:10-04:00 | |
| 838920 | MCDERMOTT WILL & SCHULTE LLP 84d90496-b341-4dcd-ad43-bbd0b35122b7 | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ALLERGAN, INC. | 2009 | third_quarter | PHA | Issues related to Section 340B of the Public Health Service Act. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-10-19T15:12:26-04:00 | |
| 838950 | SANOFI US SERVICES INC. f684f31b-db82-4ae1-8d68-de29d0c1c872 | Q3 | SANOFI US SERVICES INC. | 56838 | SANOFI US SERVICES INC | 2009 | third_quarter | PHA | Issues related to the final regulations implementing those provisions of HR4896 "National Defense Authorization Act for FY2008" related to TRICARE retail pharmacy sales. | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 1470000 | 0 | 0 | 2009-10-19T15:15:39-04:00 | |
| 839731 | AKIN GUMP STRAUSS HAUER & FELD a0352e16-348b-46a8-9804-da44451e3dc2 | Q3 | AKIN GUMP STRAUSS HAUER & FELD | 682 | PRASCO, INC. | 2009 | third_quarter | PHA | Promoting consumer benefits of authorized generic drugs | Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2009-10-19T16:02:05-04:00 | |
| 839734 | ANIMAL HEALTH INSTITUTE e18360d0-a3c8-4c2b-8dcb-bf859c8b8233 | Q3 | ANIMAL HEALTH INSTITUTE | 4037 | ANIMAL HEALTH INSTITUTE | 2009 | third_quarter | PHA | Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act; HR2400, Strategies to Address Antimicrobial Resistance Act; S510, FDA Food Safety Modernization Act; HR2749, Food Safety Enhancement Act of 2009; Affordable Health Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-10-19T16:02:06-04:00 | |
| 839943 | WALMART INC. 8497413f-6c3a-4174-970d-136f4c6fd377 | Q3 | WALMART INC. | 40305 | WALMART INC | 2009 | third_quarter | PHA | H.R. 1548 & S. 1427 - to amend title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes - Average Manufacturer's Price H.R. 616 & S. 511 - to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals H.R. 1970 & S. 956 - to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacists from the surety bond requirement under the Medicare program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Council of Economic Advisers (CEA),Energy, Dept of,Environmental Protection Agency (EPA),Federal Energy Regulatory Commission (FERC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Security Council (NSC),Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office | 1620000 | 0 | 0 | 2009-10-19T16:18:32-04:00 | |
| 840032 | UNIVERSITY OF IOWA cfa739d1-6993-4afc-8839-33b982c587e3 | Q3 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2009 | third_quarter | PHA | Increased appropriations for systems to shorten the time between development of a drug and its release to the public. FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY2009 and FY 2010 Agricultural Appropriations human factors research related to neuropharmaceuticals | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 110000 | 0 | 0 | 2009-10-19T16:24:01-04:00 | |
| 840367 | TARPLIN, DOWNS & YOUNG, LLC 12c48437-3dc4-4ad3-8a98-afdfd11e66eb | Q3 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2009 | third_quarter | PHA | **see addendum page Importation of prescription drugs (S. 525/H.R. 1298/S. 1232) RX Pedigree Pharmacy Accreditation Delay (H.R. 3663) | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-10-19T16:47:18-04:00 | |
| 840794 | WALGREEN COMPANY b84191fc-09ed-414f-91a8-5ebc32d3d664 | Q3 | WALGREEN COMPANY | 309071 | WALGREEN COMPANY | 2009 | third_quarter | PHA | S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the TRICARE Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for TRICAREe beneficiaries. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 370000 | 0 | 0 | 2009-10-19T17:18:43-04:00 | |
| 841223 | PRICEWATERHOUSECOOPERS 2204b36f-c035-4258-9db4-f9078d272743 | Q3 | PRICEWATERHOUSECOOPERS | 10764 | SCHERING-PLOUGH CORPORATION | 2009 | third_quarter | PHA | General issues affecting pharmaceutical companies | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2009-10-19T17:44:28-04:00 | |
| 841376 | HERBERT ALLEN "MIKE" AILSWORTH ace90a18-4ef5-4825-b975-0ba32ab02381 | Q3 | HERBERT ALLEN "MIKE" AILSWORTH | 290558 | SANOFI-AVENTIS U S INC | 2009 | third_quarter | PHA | General issues affecting the Pharmaceutical Industry. | HOUSE OF REPRESENTATIVES,SENATE | 22500 | 0 | 0 | 2009-10-19T17:58:14-04:00 | |
| 841932 | THE MATHIS HARPLE GROUP 92f11e13-070e-4bc6-bf72-42aedd5ebd0e | Q3 | THE MATHIS HARPLE GROUP | 322911 | PILMA | 2009 | third_quarter | PHA | Patent issues on Biologics | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2009-10-19T19:10:57-04:00 | |
| 841962 | WINSTON & STRAWN LLP 8b791f08-0912-43ab-8342-78f1475ca1bf | Q3 | WINSTON & STRAWN LLP | 41682 | FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) | 2009 | third_quarter | PHA | Represent the client on issues related to assuring a safe, reliable supply of heparin and vancomycin. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-10-19T19:17:02-04:00 | ||
| 842027 | HILL PARTNER, LLC 5c107dd3-f923-463e-a436-fcb07dd8528b | Q3 | HILL PARTNER, LLC | 317652 | S&S TECHNOLOGY | 2009 | third_quarter | PHA | Protection of the United States Prescription Drug Supply Chain from counterfeiters and mishandling during shipments | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-10-19T19:26:20-04:00 | ||
| 842270 | WINSTON & STRAWN LLP ddb2cb60-22ad-4789-98bf-9a1cd4ff744f | Q3 | WINSTON & STRAWN LLP | 41682 | ABRAXIS BIOSCIENCE LLC | 2009 | third_quarter | PHA | Issues related to safety of breast cancer drugs | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-10-19T20:15:26-04:00 | ||
| 843091 | THE RUSSELL GROUP, INC. 4b7ff037-a011-4423-9ce2-bf8f22ff9193 | Q3 | THE RUSSELL GROUP, INC. | 22688 | GENERIC PHARMACEUTICAL ASSOCIATION | 2009 | third_quarter | PHA | Issues relative to generic pharmaceuticals and generic biologics; H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill) | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-10-20T09:14:25-04:00 | |
| 843199 | SUPERVALU INC. 9f974002-529e-4efe-bd82-64f8c14201c6 | Q3 | SUPERVALU INC. | 400275287 | SUPERVALU INC | 2009 | third_quarter | PHA | Proposed legislation regarding pharmacy reimbursements. | HOUSE OF REPRESENTATIVES,SENATE | 180000 | 0 | 0 | 2009-10-20T09:19:21-04:00 | |
| 843331 | ACADEMY OF MANAGED CARE PHARMACY 2fda0b20-76df-4186-bf97-3850ee4ef183 | Q3 | ACADEMY OF MANAGED CARE PHARMACY | 48793 | ACADEMY OF MANAGED CARE PHARMACY | 2009 | third_quarter | PHA | Health care reform with respect to pharmacy issues and the professional role of pharmacists; legislation relating to medication therapy management programs; legislation relating to importation of prescription drugs; legislation granting the FDA authority to approve follow-on biologic products; legislation relating to settlement agreements between brand-name and generic manufacturers; legislation promoting the use of generic drugs generally. | HOUSE OF REPRESENTATIVES,SENATE | 169000 | 0 | 0 | 2009-10-20T09:33:37-04:00 | |
| 843424 | BLUECROSS BLUESHIELD OF TENNESSEE 5abc358d-39a5-463d-919a-56f5fc2b7f7f | Q3 | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2009 | third_quarter | PHA | Biologicals S. 623 E-Prescribing - Enhanced Health Care Value for All Act Comparative Effectiveness Research Act | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-10-20T09:40:54-04:00 | |
| 843661 | APOTEX CORP. e86c173c-11c0-4890-bfb1-0c0ac33ac481 | Q3 | APOTEX CORP. | 310973 | APOTEX CORP. | 2009 | third_quarter | PHA | S. 369, the Preserve Access to Affordable Pharmaceuticals Act HR 1706, the Protecting Consumer Access to Generic Drugs Act S. 1315, the Drug Price Competition Act of 2009 HR 3200, Subtitle C - Food & Drug Administration, Section 2563, Protecting Consumer Access to Generic Drugs HR 3200, Subtitle C, Food & Drug Administration, Part 2, Biosimilars Section 2565, Licensure Pathway for Biosimilar Biological Products HR 1427, the Promoting Innovation and Access to Life Savings Medicine Act HR 1548, Pathway for Biosimilars Act | Congressional Budget Office (CBO),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2009-10-20T09:59:27-04:00 | |
| 843849 | NOVO NORDISK INC. f9c95eea-6e3c-4d54-8697-aa538af6ace6 | Q3 | NOVO NORDISK INC. | 284790 | NOVO NORDISK INC. | 2009 | third_quarter | PHA | H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal preemption | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE | 430000 | 0 | 0 | 2009-10-20T10:08:21-04:00 | |
| 844014 | ROETZEL & ANDRESS, LPA fb6c4a15-6bae-472e-8b7f-f3baabb52af9 | Q3 | ROETZEL & ANDRESS, LPA | 304452 | LILLY USA | 2009 | third_quarter | PHA | matters pertaining to pharmacy matters | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-10-20T10:15:32-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);